Literature DB >> 9650890

Novel S100 proteins in human esophageal epithelial cells: CAAF1 expression is associated with cell growth arrest.

J Hitomi1, T Kimura, E Kusumi, S Nakagawa, S Kuwabara, K Hatakeyama, K Yamaguchi.   

Abstract

CAAF1 and CAAF2, newly identified calcium-binding proteins from bovine amniotic fluid, have been revealed to be members of the S100 protein family preferentially produced by fetal squamous epithelial cells, including epidermal keratinocytes. Having previously cloned the cDNA of human CAAF1 protein from the esophageal epithelium, we report here on the characteristic expression pattern of CAAF1 and related S100 proteins in human esophageal epithelial cells. Normal cells of the human esophageal epithelium expressed CAAF1, and also expressed the homologous novel S100 proteins including CAAF2, MRP8, and MRP14, but not S100alpha. An immunohistochemical study with specific monoclonal antibodies against CAAF1 proteins demonstrated that CAAF1 proteins were produced by the esophageal epithelial cells in the process of cell differentiation. The immature proliferating cells in the epithelium did not produce CAAF1 proteins, but the differentiated cells expressed CAAF1, which overlay the immature cells and were stratifying in the epithelium. These CAA 1-producing cells did not show any proliferating activities. Esophageal carcinoma cells did not express CAAF1, except for the keratinized cells with no proliferating activity. In addition, the forced expression of CAAF1 proteins in the carcinoma cells resulted in a marked decrease in DNA synthesis. These findings indicate that human esophageal epithelial cells express the multiple genes of S100 proteins including CAAF proteins, and that CAAF1 is closely associated with the terminal differentiation of these cells. CAAF1 expression also might play some role in cell growth.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9650890     DOI: 10.1679/aohc.61.163

Source DB:  PubMed          Journal:  Arch Histol Cytol        ISSN: 0914-9465


  7 in total

1.  Proteomic but not enzyme-linked immunosorbent assay technology detects amniotic fluid monomeric calgranulins from their complexed calprotectin form.

Authors:  Irina A Buhimschi; Catalin S Buhimschi; Carl P Weiner; Tatsuji Kimura; Benjamin D Hamar; Anna K Sfakianaki; Errol R Norwitz; Edmund F Funai; Elena Ratner
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

Review 2.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

3.  Differential expression of S100 gene family in human esophageal squamous cell carcinoma.

Authors:  Junfang Ji; Liqun Zhao; Xiuqin Wang; Chuannong Zhou; Fang Ding; Lei Su; Chunlin Zhang; Xuezheng Mao; Min Wu; Zhihua Liu
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-04       Impact factor: 4.553

4.  Bioinorganic Explorations of Zn(II) Sequestration by Human S100 Host-Defense Proteins.

Authors:  Lisa S Cunden; Elizabeth M Nolan
Journal:  Biochemistry       Date:  2018-03-06       Impact factor: 3.162

5.  Loss of myeloid-related proteins 8 and myeloid-related proteins 14 expression in human esophageal squamous cell carcinoma correlates with poor differentiation.

Authors:  Jian-Ping Kong; Fang Ding; Chuan-Nong Zhou; Xiu-Qin Wang; Xiao-Ping Miao; Min Wu; Zhi-Hua Liu
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

6.  Tumour inflammation signature and expression of S100A12 and HLA class I improve survival in HPV-negative hypopharyngeal cancer.

Authors:  Michael Mints; David Landin; Anders Näsman; Leila Mirzaie; Ramona Gabriela Ursu; Mark Zupancic; Linda Marklund; Tina Dalianis; Eva Munck-Wikland; Torbjörn Ramqvist
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

7.  S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma.

Authors:  Ali Khammanivong; Chengxing Wang; Brent S Sorenson; Karen F Ross; Mark C Herzberg
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.